4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-288632
Chief Legal Officer sold 1,635 shares at $10.59 ($17,315)
- Chief Legal Officer acquired 1,635 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2025-11-17 | Option exercise 10b5-1 | +1,635 | $4.14 | $6,769 | 5,229 | D |
| Bizily Scott Chief Legal Officer | 2025-11-17 | Sale 10b5-1 | −1,635 | $10.59 | $17,315 | 3,594 | D |
| Derivatives | |||||||
| Bizily Scott Chief Legal Officer | 2025-11-17 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,635 | 75,230 | D | ||
| Open-market sales · 1,635 sh · avg $10.59 · $17,315 | |||||||
Loading xslF345X05/ownership.xml…